These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Conversion to sirolimus in pediatric renal transplantation recipients. Garcia CD, Bittencourt VB, Alves AB, Garcia VD, Tumelero A, Antonello JS, Malheiros D. Transplant Proc; 2006 Nov; 38(6):1901-3. PubMed ID: 16908317 [Abstract] [Full Text] [Related]
17. Early sirolimus therapy in renal transplant recipients at high risk: is it justified? Halim MA, Al-Otaibi T, Johny KV, Hamid MH, Al-Waheeb S, Hasaneen H, Awadain WH, Nawas KM, El-Sayed A, Said T, Nair MP, Nampoory MR. Transplant Proc; 2009 Sep; 41(7):2784-8. PubMed ID: 19765435 [Abstract] [Full Text] [Related]
18. Evolution of glomerular filtration rate, renal injury markers, anemia, and angiotensin blockers use after change from calcineurin inhibitors to sirolimus in transplant patients with neoplasia versus chronic allograft nephropathy. Luna E, Cerezo I, Macias R, Villa J, Martinez C, Cubero J, Martinez R, Ferreira F, García C. Transplant Proc; 2011 Sep; 43(6):2187-90. PubMed ID: 21839229 [Abstract] [Full Text] [Related]
19. Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy. Falger JC, Mueller T, Arbeiter K, Boehm M, Regele H, Balzar E, Aufricht C. Pediatr Transplant; 2006 Jun; 10(4):474-8. PubMed ID: 16712606 [Abstract] [Full Text] [Related]
20. Improved 24-hour blood pressure control with sirolimus versus calcineurin inhibitor based immunosuppression in renal transplant recipients. Steigerwalt SP, Brar N, Dhungel A, Butcher D, Steigerwalt S, El-Ghouroury M, Provenzano R. Transplant Proc; 2009 Dec; 41(10):4184-7. PubMed ID: 20005365 [Abstract] [Full Text] [Related] Page: [Next] [New Search]